Serum GP73, a Marker for Evaluating Progression in Patients With Chronic HBV Infections

PLoS ONE - United States
doi 10.1371/journal.pone.0053862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients With Normal or Slightly Raised ALT

Scientific Reports
Multidisciplinary
2019English

Rt269I Type of Hepatitis B Virus (HBV) Leads to HBV E Antigen Negative Infections and Liver Disease Progression via Mitochondrial Stress Mediated Type I Interferon Production in Chronic Patients With Genotype C Infections

Frontiers in Immunology
AllergyImmunology
2019English

Fagocytic Activity of Peripheral Blood Monocytes in Patients With HBV-Infections

Clinical & experimental pathology
2017English

Serum HBV RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection

Hepatology
MedicineHepatology
2019English

Virology and Histopathology in Patients With Chronic HBV Infection in Bulgaria

Journal of Medical and Dental Practice
2018English

Evaluation of CD64 Index in HBV and in Chronic HCV Infections

Open Journal of Gastroenterology
2017English

Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection

Farmeconomia. Health economics and therapeutic pathways
2008English

Serum Free Fatty Acid Concentration as a Surrogate Marker for Serum Carnitine Status in Patients With Liver Cirrhosis

Acta Hepatologica Japonica
Hepatology
2013English

Retinal Thinning as a Marker of Disease Progression in Patients With Wolfram Syndrome

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy